FDA Approved: FLUDEOXYGLUCOSE F 18 — Original Application (The University of Utah DBA Cyclotron Radiochemistry Lab / Huntsman Cancer Institute)

View source ↗

Summary

FDA approved the original application for Fludeoxyglucose F-18 as a radiopharmaceutical imaging agent for PET scans, developed by the University of Utah's Cyclo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cancer
• Cardiovascular Disease
• Epilepsy
• Ischemic Heart Disease

Drugs mentioned

• Fludeoxyglucose F-18 (Fludeoxyglucose F-18)

Snippet

ORIG AP for FLUDEOXYGLUCOSE F 18 (FLUDEOXYGLUCOSE F 18)